A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same...

por Egan, Kevin P., Awasthi, Sita, Tebaldi, Giulia, Hook, Lauren M., Naughton, Alexis M., Fowler, Bernard T., Beattie, Mitchell, Alameh, Mohamad-Gabriel, Weissman, Drew, Cohen, Gary H., Friedman, Harvey M.
Publicado 2023

Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine

por Hook, Lauren M., Awasthi, Sita, Cairns, Tina M., Alameh, Mohamad-Gabriel, Fowler, Bernard T., Egan, Kevin P., Sung, Molly M. H., Weissman, Drew, Cohen, Gary H., Friedman, Harvey M.
Publicado 2022

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine i...

por Awasthi, Sita, Onishi, Motoyasu, Lubinski, John M., Fowler, Bernard T., Naughton, Alexis M., Hook, Lauren M., Egan, Kevin P., Hagiwara, Masaki, Shirai, Seiki, Sakai, Akiho, Nakagawa, Takayuki, Goto, Kumiko, Yoshida, Osamu, Stephens, Alisa J., Choi, Grace, Cohen, Gary H., Katayama, Kazufumi, Friedman, Harvey M.
Publicado 2023